Cargando…
Lipid lowering in patients 75 years and older
More than twenty years ago, knowledge about the importance of cholesterol absorption and the potential therapeutic effect of its inhibition led to the discovery and clinical application of the first and only cholesterol absorption inhibitor to date – ezetimibe. Since then, ezetimibe has become a wel...
Autores principales: | Makhmudova, Umidakhon, Schulze, P Christian, Davis, Harry R, Weingärtner, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554361/ https://www.ncbi.nlm.nih.gov/pubmed/34754397 http://dx.doi.org/10.4330/wjc.v13.i10.526 |
Ejemplares similares
-
Phytosterols and Cardiovascular Disease
por: Makhmudova, Umidakhon, et al.
Publicado: (2021) -
Intensive lipid-lowering therapy for early achievement of guideline-recommended LDL-cholesterol levels in patients with ST-elevation myocardial infarction (“Jena auf Ziel”)
por: Makhmudova, Umidakhon, et al.
Publicado: (2023) -
Different Perspectives of Patients and Physicians on LDL-C Target Achievement in the Treatment of Hypercholesterolemia: Results on Secondary Prevention from the German PROCYON Survey
por: Makhmudova, Umidakhon, et al.
Publicado: (2022) -
Intensive lipid-lowering therapy, time to think beyond low-density lipoprotein cholesterol
por: Abdalwahab, Ahmed, et al.
Publicado: (2021) -
The effects of lipids on channel function
por: Lee, Anthony G
Publicado: (2009)